Theodore Samuels R.'s Insider Trades & SAST Disclosures
Theodore Samuels R.'s most recent trade in Bristol-Myers Squibb Co. was a trade of 3,562 Deferred Share Units done . Disclosure was reported to the exchange on Feb. 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Theodore Samuels R..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 3,562 | 56,856 | - | - | Deferred Share Units | |
| Iron Mountain Inc. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 45 | 4,691 | - | - | Phantom Stock | |
| Iron Mountain Inc. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 283 | 4,645 | - | - | Phantom Stock | |
| Bristol-Myers Squibb Co. | Theodore Samuels R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 884 | 52,748 | - | - | Deferred Share Units | |
| Centene Corp. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 414 | 14,036 (0%) | 0% | 0 | Common Stock | |
| Centene Corp. | Theodore R. Samuels | Director | Purchase of securities on an exchange or from another person at price $ 58.86 per share. | 13 Dec 2024 | 5,000 | 23,000 (0%) | 0% | 58.9 | 294,300 | Common Stock |
| Iron Mountain Inc. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2024 | 38 | 4,362 | - | - | Phantom Stock | |
| Iron Mountain Inc. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 241 | 4,324 | - | - | Phantom Stock | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 966 | 51,297 | - | - | Deferred Share Units | |
| Centene Corp. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 335 | 13,622 (0%) | 0% | 0 | Common Stock | |
| Iron Mountain Inc. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2024 | 305 | 4,082 | - | - | Phantom Stock | |
| Iron Mountain Inc. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2024 | 42 | 3,776 | - | - | Phantom Stock | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 1,203 | 49,712 | - | - | Deferred Share Units | |
| Centene Corp. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 377 | 13,287 (0%) | 0% | 0 | Common Stock | |
| Iron Mountain Inc. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 2,385 | 3,734 | - | - | Phantom Stock | |
| Centene Corp. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 2,916 | 12,910 (0%) | 0% | 0 | Common Stock | |
| Iron Mountain Inc. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 385 | 1,349 | - | - | Phantom Stock | |
| Iron Mountain Inc. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2024 | 25 | 964 | - | - | Phantom Stock | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 922 | 47,858 | - | - | Deferred Share Units | |
| Centene Corp. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 323 | 9,994 (0%) | 0% | 0 | Common Stock | |
| Bristol-Myers Squibb Co. | Theodore Samuels R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 4,314 | 46,936 | - | - | Deferred Share Units | |
| Iron Mountain Inc. | Samuels Theodore R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 429 | 938 | - | - | Phantom Stock | |
| Iron Mountain Inc. | R. Theodore Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 26 | 508 | - | - | Phantom Stock | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 950 | 42,103 | - | - | Deferred Share Units | |
| Centene Corp. | R. Theodore Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 433 | 9,671 (0%) | 0% | 0 | Common Stock | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Purchase of securities on an exchange or from another person at price $ 49.81 per share. | 20 Nov 2023 | 8,500 | 35,500 (0%) | 0% | 49.8 | 423,385 | Common Stock, $0.10 par value |
| Iron Mountain Inc. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2023 | 456 | 482 | - | - | Phantom Stock | |
| Iron Mountain Inc. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2023 | 25 | 25 | - | - | Phantom Stock | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 839 | 40,700 | - | - | Deferred Share Units | |
| Centene Corp. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 469 | 9,238 (0%) | 0% | 0 | Common Stock | |
| Iron Mountain Inc. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.01 per share. | 17 Jul 2023 | 2,264 | 2,264 (0%) | 0% | 0.0 | 23 | Common Stock, par value $.01 per share |
| Iron Mountain Inc. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 2,264 | 6,955 | - | - | Phantom Stock | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 762 | 39,494 | - | - | Deferred Share Units | |
| Centene Corp. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 468 | 8,768 (0%) | 0% | 0 | Common Stock | |
| Centene Corp. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 2,947 | 8,299 (0%) | 0% | 0 | Common Stock | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 703 | 38,412 | - | - | Deferred Share Units | |
| Centene Corp. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 440 | 5,352 (0%) | 0% | 0 | Common Stock | |
| Centene Corp. | Theodore R. Samuels | Director | 31 Mar 2023 | 300 | 0 (0%) | 0% | 0 | Common Stock | ||
| Centene Corp. | Theodore R. Samuels | Director | Purchase of securities on an exchange or from another person at price $ 71.88 per share. | 08 Feb 2023 | 7,000 | 11,912 (0%) | 0% | 71.9 | 503,160 | Common Stock |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 2,807 | 37,709 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 677 | 34,624 | - | - | Deferred Share Units | |
| Centene Corp. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 382 | 4,912 (0%) | 0% | 0 | Common Stock | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 685 | 33,712 | - | - | Deferred Share Units | |
| Centene Corp. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 349 | 4,529 (0%) | 0% | 0 | Common Stock | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 633 | 32,786 | - | - | Deferred Share Units | |
| Centene Corp. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 376 | 4,180 (0%) | 0% | 0 | Common Stock | |
| Perrigo Company plc | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 7,778 | 7,778 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Theodore R. Samuels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.57 per share. | 17 May 2022 | 6,599 | 26,693 (0%) | 0% | 38.6 | 254,523 | Ordinary Shares |
| Perrigo Company plc | Theodore R. Samuels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2022 | 6,599 | 0 | - | - | Restricted Stock Units | |
| Centene Corp. | Theodore R. Samuels | Director | Purchase of securities on an exchange or from another person at price $ 80.94 per share. | 28 Apr 2022 | 6,270 | 11,000 (0%) | 0% | 80.9 | 507,494 | Common Stock |
| Centene Corp. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 2,323 | 3,804 (0%) | 0% | 0 | Common Stock | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 667 | 31,923 | - | - | Deferred Share Units | |
| Centene Corp. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 82.02 per share. | 31 Mar 2022 | 381 | 1,481 (0%) | 0% | 82.0 | 31,250 | Common Stock |
| Centene Corp. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 10,000 | 10,000 | - | - | Common Stock | |
| Centene Corp. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 1,100 | 1,100 (0%) | 0% | 0 | Common Stock | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 3,067 | 31,255 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2021 | 761 | 27,956 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 802 | 26,969 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 629 | 25,979 | - | - | Deferred Share Units | |
| Perrigo Company plc | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 6,599 | 6,599 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Theodore R. Samuels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2021 | 5,804 | 0 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Theodore R. Samuels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.96 per share. | 07 May 2021 | 5,804 | 20,094 (0%) | 0% | 43.0 | 249,340 | Ordinary Shares |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 514 | 25,159 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 3,054 | 24,644 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2020 | 523 | 21,421 | - | - | Deferred Share Units | |
| Perrigo Company plc | Theodore R. Samuels | Director | Purchase of securities on an exchange or from another person at price $ 46.91 per share. | 09 Nov 2020 | 4,500 | 18,118 (0%) | 0% | 46.9 | 211,112 | Ordinary Shares |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 539 | 20,741 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 552 | 20,049 | - | - | Deferred Share Units | |
| Perrigo Company plc | Theodore R. Samuels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 6,054 | 0 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Theodore R. Samuels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.76 per share. | 15 May 2020 | 6,054 | 14,290 (0%) | 0% | 52.8 | 319,409 | Ordinary Shares |
| Perrigo Company plc | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2020 | 5,804 | 5,804 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb Co. | Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2020 | 583 | 19,352 | - | - | Deferred Share Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges